Article
Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.
The Journal of molecular diagnostics : JMD - 1 Feb 2006
Li Jin, Harris Lyndsay, Mamon Harvey, Kulke Matthew H, Liu Wei-Hua, Zhu Penny, Mike Makrigiorgos G
Abstract excerpt
Apoptotic and necrotic tumor cells release DNA into plasma, providing an accessible tumor biomarker. Tumor-released plasma-circulating DNA can be screened for tumor-specific genetic changes, including mutation, methylation, or allelic imbalance. However, technical problems relating to the quantity and quality of DNA collected from plasma hinder downstream genetic screening and reduce biomarker detection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
